Home › Funds › ACORN CAPITAL ADVISORS, LLC › QTTB
ACORN CAPITAL ADVISORS, LLC position in QTTB
Q32 BIO INC · Health Care
ACORN CAPITAL ADVISORS, LLC reported holding 216,171 shares of QTTB (Q32 BIO INC) in its Q3 2026 13F filing — a position valued at US$1.8M, representing 0.49% of its reported portfolio and ranking #18 among its reported holdings. ACORN CAPITAL ADVISORS, LLC has disclosed QTTB holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How ACORN CAPITAL ADVISORS, LLC's QTTB position evolved
ACORN CAPITAL ADVISORS, LLC first disclosed a stake in QTTB in Q4 2024 at 803,425 shares (US$2.8M). Across 8 filings, ACORN CAPITAL ADVISORS, LLC increased the stake 0 time(s), trimmed it 3 time(s) and left it unchanged 4 time(s). The most recent filing (Q3 2026) shows 216,171 shares valued at US$1.8M. Notable position changes include a 39% trim in Q4 2025 (shares rose 93% over the following quarter), a 36% trim in Q1 2026 (shares rose 98% over the following quarter), a 31% trim in Q2 2026 (shares fell 35% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 803.42K | $2.76M | New |
| Q1 2025 | 803.42K | $1.33M | Hold |
| Q2 2025 | 803.42K | $1.20M | Hold |
| Q3 2025 | 803.42K | $1.59M | Hold |
| Q4 2025 | 493.43K | $1.64M | Reduce |
| Q1 2026 | 315.05K | $2.02M | Reduce |
| Q2 2026 | 216.17K | $2.75M | Reduce |
| Q3 2026 | 216.17K | $1.79M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About QTTB and 13F data
QTTB (Q32 BIO INC) is a Health Care company. 66 other funds we track also report a position in QTTB — the largest reported positions include ORBIMED ADVISORS LLC (US$52.6M), Boxer Capital Management, LLC (US$40.1M), BVF INC/IL (US$29.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding QTTB
- ORBIMED ADVISORS LLC 4.13M sh · $52.59M · Q2 2026
- Boxer Capital Management, LLC 3.15M sh · $40.12M · Q2 2026
- BVF INC/IL 2.35M sh · $29.94M · Q2 2026
- Atlas Venture Life Science Advisors, LLC 2.72M sh · $22.47M · Q3 2026
- Opaleye Management Inc. 931.00K sh · $11.86M · Q2 2026
- Sio Capital Management, LLC 529.15K sh · $4.38M · Q3 2026
- Sanofi 244.08K sh · $2.02M · Q3 2026
- Velan Capital Investment Management LP 120.00K sh · $992.40K · Q3 2026
- Nutshell Asset Management Ltd 98.30K sh · $812.93K · Q3 2026
- B Group, Inc. 65.00K sh · $537.55K · Q3 2026
More on ACORN CAPITAL ADVISORS, LLC
FAQ
How long has ACORN CAPITAL ADVISORS, LLC held QTTB?
ACORN CAPITAL ADVISORS, LLC has disclosed QTTB holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
What is ACORN CAPITAL ADVISORS, LLC's current position in QTTB?
As of Q3 2026, ACORN CAPITAL ADVISORS, LLC holds 216.17K shares of QTTB (Q32 BIO INC), valued at $1.79M, representing 0.49% of its reported portfolio and ranking #18.
Has ACORN CAPITAL ADVISORS, LLC been buying or selling QTTB?
In the latest 13F filing (Q3 2026), ACORN CAPITAL ADVISORS, LLC held unchanged its position in QTTB.
Which other funds hold QTTB?
Other major institutional holders of QTTB include ORBIMED ADVISORS LLC, Boxer Capital Management, LLC, BVF INC/IL, among 66 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.